Navigation Links
First Molecular Tem-PCR Test to Identify Multiple Forms of Staph and MRSA Obtains CLIA Certificate
Date:8/4/2008

Identifies deadly hospital pathogens

A single, fast and accurate test identifies four Staph strains

simultaneously

HUNTSVILLE, Ala., Aug. 4 /PRNewswire/ -- Diatherix Laboratories, an independent clinical reference laboratory located in the Hudson-Alpha Institute for Biotechnology, announced today it has received its Clinical Laboratory Improvement Amendment (CLIA) certificate* for its proprietary licensed testing process, Target Enriched Multiplex Polymerase Chain Reaction (Tem-PCR). This molecular differential diagnostic technology is the first Tem- PCR test introduced to the clinical market which is able to identify multiple pathogens, both viral and bacterial in a single test. In less than four hours Tem-PCR can simultaneously differentiate pathogens with Staphylococcus and determine their associated drug resistance. Tem-PCR can identify four types of Staphylococcus strains, including the increasingly important bacterium known as Methicillin-resistant Staphylococcus aureus (MRSA).

The Centers for Disease Control and Prevention (CDC) has reported that MRSA infections have doubled in the past six years. The ability to accurately identify these pathogens is important because, beginning in October 2008, hospitals across the country may no longer receive Medicare reimbursement for many hospital acquired infections.

Prior to the Tem-PCR molecular technology, it was not possible to quickly and effectively differentiate between hospital-acquired infections (HAI) and community-acquired infections (CAI) in a single molecular test. Unlike hospital acquired MRSA which affects patients in a hospital, community-acquired MRSA often occurs in healthy people who are not receiving medical care and hospitalization. The ability to differentiate between CA-MRSA and HA-MRSA may assist hospitals in preventing non-reimbursement for MRSA infections.

"This revolutionary molecular testing technolog
'/>"/>

SOURCE Diatherix Laboratories Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
3. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
4. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
5. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
6. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
7. Tainted Chinese Food Ingredients First Discovered in 2005
8. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
9. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
10. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
11. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013 Valeant ... VRX ) (TSX: VRX) today announced ... at its 2013 annual meeting of ... the vote for the election of ... H. Farmer235,731,9341,964,748Robert A. Ingram233,865,8763,830,806Theo Melas-Kyriazi237,081,508615,174G. Mason ...
(Date:5/21/2013)... CINCINNATI , May 21, 2013  Tom Daulton, CEO ... named Dealmaker of the Year by the Cincinnati ... Daulton, who was nominated by another local top executive who ... the Mammotome® brand from Ethicon Endo-Surgery in March of 2010. ... Deal Maker Awards program, presented by Huntington Bank, on May ...
(Date:5/21/2013)... N.J. , May 21, 2013 /PRNewswire-iReach/ -- The ... in NJ has attracted the greatest number of ... its President, Mark Alexay .  ... plans to attend this year.  The show,s still 4 ... different companies.  This is a big surprise and ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces 2013 Annual Meeting Results 2Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 2Tom Daulton, Mammotome CEO, Named ACG Dealmaker of the Year 3Emerging Pharma at ChemOutsourcing 2013 in Record Numbers for Upcoming September Show 2
... Ellman International, Inc ., a New York based manufacturer ... today announced the appointment of Dennis S. Herman to ... Herman brings over 20 years of sales leadership ...  "Dennis, proven success in leading sales teams to significant ...
... 1, 2011 Lance® Sandwich Crackers is partnering ... support the organization,s efforts to find better treatments and a ... diabetes is an autoimmune disease that can strike at any ... insulin needed to turn food into energy.  People with the ...
Cached Medicine Technology:Ellman International Announces New US Sales Executive 2Lance® Joins JDRF in the Fight Against Type 1 Diabetes 2Lance® Joins JDRF in the Fight Against Type 1 Diabetes 3
(Date:5/21/2013)... MedMar Healing Center announces their participation in the CannaCommunity ... businesses, including MedMar Healing Center, doctors, and clubs, are coming ... to raise food to help area kids who have been ... years. , “We like being able to give back ... Chloupek of MedMar Healing Center. “Taking part in the food ...
(Date:5/21/2013)... (May 21, 2013) Research into genetic features of ... of Colorado School of Medicine may lead to improved ... paper published online by JAMA . , The ... survival in some cases of pulmonary fibrosis, a chronic ... As a result of the study, researchers may want ...
(Date:5/21/2013)... New York, New York (PRWEB) May 21, 2013 ... da Vinci surgery robot lawsuit is nearing its ... According to Bloomberg.com, during closing statements yesterday, an ... car dealership, alleging the company wanted to tie sales ... to do all the training to keep control of ...
(Date:5/21/2013)... 2013 Two executives from human resources ... identify which strategies can be most effective to better ... the members who are taking them, in an upcoming ... “How to Manage Specialty Drugs to Reduce Costs and ... the main driver for rising prescription drug costs, which ...
(Date:5/21/2013)... va (PRWEB) May 21, 2013 ... critical technology and management consulting solutions to the ... of Business Development. In the newly created ... leading all aspects of the firm’s business development ... and proposal management functions, and leading strategies to ...
Breaking Medicine News(10 mins):Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4Health News:Consulting Firm Execs to Discuss Strategies for Effective Management of Specialty Drugs in AIS’s May 30 Webinar 2Health News:Octo Consulting Group Appoints Tracy Denny as Vice President of Business Development 2
... Jenifer Goodwin HealthDay Reporter , THURSDAY, Sept. ... a placebo pill to treat a low libido reported ... is evidence of the powerful and somewhat mysterious mind-body ... Viagra and Cialis revolutionized the treatment of male sexual ...
... Texas is recruiting patients for a Phase III lung ... previously treated patients. The trial will evaluate the ... for the treatment of Non-Small Cell Lung Cancer (NSCLC). ... Cancer Immunotherapy) study is expected to be one of ...
... bacteria that inhabit the intestine provide the environmental trigger ... who are genetically susceptible to inflammatory bowel disease (IBD), ... researchers has found. Inflammatory bowel disease results ... immune system and the microbes that inhabit the intestine. ...
... at Washington University School of Medicine in St. Louis ... the effectiveness of radiation for hard-to-treat cancers. The ... Cancer Institute , focuses on the role of the ... and functioning of blood vessel networks that feed malignant ...
... By Kathleen Doheny HealthDay Reporter , ... smoking in workplaces and public settings seem to show ... is linked with a decline in hospital admissions for ... to tobacco smoke increases the incidence and severity of ...
... -- A new study is helping unravel an enduring mystery ... affected by the disorder than girls. An international team ... and Mental Health in Toronto, examined specific genes in almost ... others with intellectual disability. They then compared that data to ...
Cached Medicine News:Health News:Placebo Pill Gives Boost to Some Women's Sex Drive 2Health News:Bacteria identified that may lead to inflammatory bowel disease in certain individuals 2Health News:Novel target for existing drug may improve success of radiation therapy 2Health News:Novel target for existing drug may improve success of radiation therapy 3Health News:Smoke-Free Laws May Help Kids Breathe Easier 2Health News:Research Sheds Light on Why Autism Is More Prevalent in Boys 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: